National Biz News

All Business Stories for You!

News

StoxBox: Buy Aarti Drugs for 16percentage Upside

StoxBox has issued a “Buy” rating for Aarti Drugs Limited, projecting a target price of INR 602, reflecting a 16% upside from the current market price (CMP). This recommendation is based on a valuation of 23x FY26e earnings and highlights…